CTKB - Cytek Biosciences, Inc.
NEXT EARNINGS:
Feb 26, 2026
(in 1 day)
EPS Est: $0.02
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$6.00
DETAILS
HIGH:
$6.00
LOW:
$6.00
MEDIAN:
$6.00
CONSENSUS:
$6.00
UPSIDE:
37.61%
Market Cap:
557.49M
Volume:
441,106
Avg Volume:
1,021,531
52 Week Range:
2.37-6.18
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
1.30
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
663
IPO Date:
2021-07-23
EPS (TTM):
-0.05
P/E Ratio:
-140.81
Revenue (TTM):
200.45M
Total Assets:
499.50M
Total Debt:
17.02M
Cash & Equiv:
98.72M
Rev Growth (5Y):
28.2%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-4.8%
Debt/Equity:
0.04
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-05 | $-0.01 | $0.01 | -200.0% | $52.3M | $58.8M | -11.1% |
| 2025-08-06 | $0.01 | $-0.02 | +150.0% | $45.6M | $46.3M | -1.6% |
| 2025-05-08 | $-0.09 | $-0.04 | -125.0% | $41.5M | $42.7M | -2.8% |
| 2025-02-27 | $0.07 | $0.05 | +40.0% | $57.5M | $59.4M | -3.2% |
| 2024-11-05 | $0.01 | $0.00 | +166.7% | $51.5M | $60.9M | -15.4% |
| 2024-08-06 | $-0.08 | $-0.03 | -166.7% | $46.6M | $50.7M | -8.1% |
| 2024-05-08 | $-0.05 | $-0.05 | 0.0% | $44.9M | $43.6M | +2.9% |
| 2024-03-13 | $0.07 | $0.03 | +133.3% | $58.2M | $56.6M | +2.9% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 200.45M | 193.01M | 164.04M | 127.95M | 92.84M | 57.88M |
| Net Income | (6.02M) | (12.15M) | 2.58M | 3.00M | 19.41M | (16.83M) |
| EPS | -0.05 | -0.09 | 0.02 | 0.03 | 0.02 | -0.13 |
| Total Assets | 499.50M | 494.46M | 519.48M | 463.31M | 219.98M | 70.36M |
| Total Debt | 17.02M | 14.14M | 18.09M | 0 | 2.77M | 0 |
| Cash & Equivalents | 98.72M | 167.30M | 296.60M | 364.62M | 165.23M | 30.12M |
| Operating Cash Flow | 25.38M | 5.28M | (12.23M) | 4.63M | 15.16M | (13.75M) |
| Free Cash Flow | 21.85M | 454,000 | (22.10M) | 266,000 | 13.61M | (14.72M) |
| FCF per Share | 0.17 | 0.00 | -0.16 | 0.00 | 0.10 | -0.11 |
| Book Value | 395.74M | 393.06M | 425.30M | 405.04M | (16.03M) | (41.70M) |
| Cash & ST Investments | 277.86M | 262.41M | 341.15M | 364.62M | 165.23M | 30.12M |
| ROC Equity | -0.02 | -0.03 | 0.01 | 0.01 | N/A | N/A |